C12N 9/1018
Carboxy- and carbamoyl transferases
Official title: {Carboxy- and carbamoyl transferases (2.1.3)}
C12N9/1018 (Carboxy- and carbamoyl transferases) appears on 85 US grants and 114 published applications in this corpus.
Search patents in C12N- Granted patents
- 85
- Published applications
- 114
- Assignees
- 65
- Inventors
- 240
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 3 |
| 2004 | 2 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 3 |
| 2007 | 3 | 0 |
| 2008 | 0 | 4 |
| 2009 | 1 | 1 |
| 2010 | 3 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 4 |
| 2013 | 1 | 2 |
| 2014 | 2 | 3 |
| 2015 | 3 | 4 |
| 2016 | 3 | 7 |
| 2017 | 2 | 10 |
| 2018 | 5 | 8 |
| 2019 | 10 | 9 |
| 2020 | 10 | 12 |
| 2021 | 8 | 8 |
| 2022 | 6 | 5 |
| 2023 | 2 | 5 |
| 2024 | 6 | 5 |
| 2025 | 4 | 11 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency29 Sep 2026US 12,747,429 B2The Trustees of the University of Pennsylvania
- Compositions and methods for the treatment of metabolic liver disorders3 Feb 2026US 12,540,335 B2Poseida Therapeutics, Inc.
- Compositions and methods for treating ornithine transcarbamylase deficiency26 Aug 2025US 12,398,379 B2Arcturus Therapeutics, Inc.
- Compositions and methods for the treatment of ornithine transcarbamylase deficiency8 Jul 2025US 12,351,834 B2Arcturus Therapeutics, Inc.
- Methods of altering seed weight and seed oil content by manipulating alpha-carboxyl-transferase (a-CT) activity via carboxyl-transferase interaction (CTI) protein expression29 Apr 2025US 12,286,649 B2The Curators of the University of Missouri
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- Compositions and methods for the treatment of metabolic liver disorders30 Jul 2026US 2026/0218236 A1Poseida Therapeutics, Inc.
- Fermentative production guanidinoacetic acid (gaa) from serine by attenuating l serine ammonia lyase activity in microorganisms30 Jul 2026US 2026/0218253 A1Evonik Operations GmbH
- Compositions and methods for treating ornithine transcarbamylase deficiency19 Mar 2026US 2026/0078356 A1Arcturus Therapeutics, Inc.
- Adeno-associated virus virion for treating ornithine transcarbamylase deficiency6 Nov 2025US 2025/0339480 A1Gene Therapy Research Institution Co., Ltd.
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- mRNA for use in treatment of human genetic diseases131US 8,853,377 B2Shire Human Genetic Therapies, Inc. · 2014
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor91US 8,318,480 B2The Trustees of the University of Pennsylvania · 2012
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor86US 8,962,332 B2The Trustees of the University of Pennsylvania · 2015